Cargando…
Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection
Currently, there are no FDA approved antiviral drugs available to treat COVID-19 patients. Also, due to emergence of new SARS-CoV-2 variants, the protective efficacy of vaccines could be reduced, hence it is urgent to have alternative treatments for combating the SARS-CoV-2 infection. Since, there i...
Autores principales: | Bahl, Amul S., Verma, Vipin Kumar, Bhatia, Jagriti, Arya, Dharamvir Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472470/ https://www.ncbi.nlm.nih.gov/pubmed/36113631 http://dx.doi.org/10.1016/j.cbi.2022.110179 |
Ejemplares similares
-
In silico to In vivo development of a polyherbal against Haemonchus contortus
por: Rahal, Anu, et al.
Publicado: (2022) -
Seabuckthorn Pulp Oil Protects against Myocardial Ischemia–Reperfusion Injury in Rats through Activation of Akt/eNOS
por: Suchal, Kapil, et al.
Publicado: (2016) -
Corrigendum: Seabuckthorn Pulp Oil Protects against Myocardial Ischemia–Reperfusion Injury in Rats through Activation of Akt/eNOS
por: Suchal, Kapil, et al.
Publicado: (2019) -
Inhibition of TGF-β by a novel PPAR-γ agonist, chrysin, salvages β-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism
por: Rani, Neha, et al.
Publicado: (2015) -
Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol
por: Suchal, Kapil, et al.
Publicado: (2017)